DrugsControl Media Services

News Detail

CCI starts probe on alleged price fixing of key anti diabetic drugs (14-12-2017)

New Delhi, 14 Dec 2017: Competition Commission of India has initiated an investigation on drug makers Abbott, Novartis, Emcure Pharma and USV Pvt Ltd over alleged price fixing of the blockbuster anti-diabetic drug Vildagliptin, people aware of the development said.

View Details

Source : ET Health World

Related News